Novabase SGPS (NBA)
Euronext Lisbon · Portugal · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 7.100 |
|---|---|
| 52-week range | 6.880 – 9.500 |
| Return, 1 month / 3 months | −1.1% / −5.6% |
| Return, 1 year / 3 years | −15.7% / +108.3% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 22.2% |
| Worst drawdown (1 year) | -23.6% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Novabase SGPS is a Portuguese information technology company based in Lisbon. It provides consulting, software development and outsourcing services to organisations in sectors such as banking, insurance, telecommunications and the public sector. Its work covers the design and running of computer systems, applications and technology projects for clients, mainly in Portugal and other Portuguese-speaking markets. The company also develops its own software products and invests in technology ventures through its venture capital arm.
Novabase SGPS trades under the code NBA on the Euronext Lisbon in Portugal, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Novabase SGPS (NBA) trades on the Euronext Lisbon in Portugal. It last closed at EUR 7.100 on 23 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 31 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.7% and over the last three months it fell 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.4% | ||
| From 52-week high | -25.3% | ||
| Momentum | 19 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.6% | ||
| 6-month return | -16.9% | ||
| 12-month return, skipping the last month | -14.7% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 22.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.6% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | −1.1% |
| 3 months | −5.6% |
| 6 months | −16.9% |
| 1 year | −15.7% |
| 3 years | +108.3% |
| 5 years | +162.4% |
Signals
| 50-day / 200-day average | 7.103 / 8.017 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.105 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jul 2026 | EUR 0.4000 |
| 5 Jun 2025 | EUR 1.3500 |
| 6 Jun 2024 | EUR 1.7900 |
| 21 Jun 2023 | EUR 0.1000 |
| 25 Jul 2022 | EUR 0.4300 |
| 22 Nov 2019 | EUR 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.